[Commentary] On February 26, the State Council Information Office held a press conference.

At the meeting, Minister of Science and Technology Wang Zhigang said that after the outbreak of the new crown pneumonia, scientific research emergency research has been carried out quickly.

At present, China has seven new crown vaccines in phase III clinical trials.

  [Concurrent] Wang Zhigang, Minister of Science and Technology

  Complete viral gene sequencing within one week, and complete the development and marketing of nucleic acid detection reagents within 14 days.

Five technical routes for vaccine development were advanced in parallel, seven models entered phase III clinical trials, and four models were approved for conditional listing.

Participate in 10 working groups of the World Health Organization, conduct scientific and technological anti-epidemic exchanges and cooperation with the United States, Europe, Asia, Africa, Latin America, the Caribbean and other countries, share the latest results, and provide Chinese solutions.

  [Explanation] At the same time, in terms of clinical treatment and drug development, 11 drugs or treatment methods have entered the diagnosis and treatment plan, providing strong support for epidemic prevention and control.

  [Concurrent] Wu Yuanbin, Director of the Department of Social Development and Science, Ministry of Science and Technology

  A total of 11 types of drugs, including relevant Chinese medicines and prescriptions, have been incorporated into the treatment plan, which have played an important role in clinical treatment, blocking the development of mild to severe cases, and reducing the mortality rate.

New technologies including convalescent plasma and stem cells have achieved significant results in the treatment of severe and critically ill patients.

In terms of the research and development of specific drugs, the focus is on promoting the research and development of neutralizing antibodies. At present, 7 single varieties and 1 combination drug have been approved for clinical trials.

  [Explanation] Wu Yuanbin said that the next step will continue to advance scientific research on epidemic prevention and control, accelerate the iterative upgrade of vaccine and antibody drug research and development, testing technology and products, and continue to track virus mutations and the impact on vaccines, drugs, and testing reagents.

At the same time, it will speed up to make up for shortcomings and strengthen long-term layout.

  [Concurrent] Wu Yuanbin, Director of the Department of Social Development and Science, Ministry of Science and Technology

  Strengthen the construction of health science and technology innovation capacity, establish a scientific research system and rapid support mechanism combining peace and war, focus on key areas such as epidemic prevention and control, major disease prevention, reproductive health, and population aging, and increase the deployment of scientific research tasks.

Accelerate the completion of shortcomings in pathogenic research and high-end medical equipment research and development, so that technological innovation can better protect people's lives and health.

  [Explanation] At the meeting, a reporter asked questions about the reform of the evaluation mechanism for scientific and technological talents.

In this regard, Wang Zhigang said that talents play a decisive role in the development of scientific and technological innovation. It is necessary to break the simple link between the title of scientific and technological talents and the evaluation results to further stimulate the innovative vitality of talents.

  [Concurrent] Wang Zhigang, Minister of Science and Technology

  Pay attention to the ability, quality, effectiveness, and contribution of scientific researchers, and resolutely reverse the unhealthy tendency of "only papers, professional titles, academic qualifications, and awards".

Efforts should be made to reduce the burden on scientific researchers and create a good academic ecology.

And according to the laws and characteristics of different activities in basic research, applied basic research, technological innovation and achievement transformation, scientific research personnel should be created, some are the same, some are different scientific research ecology and service methods.

  Cheng Yu reports from Beijing

Editor in charge: [Ji Xiang]